Trial Profile
A Clinical Trial to Assess a Single Dose of Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2023
Price :
$35
*
At a glance
- Drugs ALLOD 2 (Primary) ; Naltrexone; Paracetamol
- Indications Migraine
- Focus Proof of concept; Therapeutic Use
- Acronyms ANODYNE1
- Sponsors Allodynic Therapeutics
- 18 Feb 2018 Status changed from recruiting to completed.
- 31 Dec 2017 Planned End Date changed from 1 Apr 2018 to 1 May 2018.
- 31 Dec 2017 Planned primary completion date changed from 1 Feb 2018 to 12 Feb 2018.